For US residents only.

Treatment Information

RYDAPT IS NOW APPROVED

What is RYDAPT?

RYDAPT® (midostaurin) capsules is an oral prescription medicine used to treat adults:

  • newly diagnosed with a certain type of acute myeloid leukemia (AML), in combination with certain chemotherapy medicines
    • Your healthcare provider will perform a test to make sure RYDAPT is right for you.
  • with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL)

It is not known if RYDAPT is safe and effective in children.

 

RYDAPT is available by prescription only.
 

If you have any questions about how RYDAPT works or why this medicine has been prescribed for you, ask your doctor or pharmacist.

FLT3 testing is required before RYDAPT can be administered

FLT3 mutation testing is performed by The Laboratory for Personalized Molecular Medicine, a subsidiary of Invivoscribe Technologies, Inc., which has gained FDA approval for its FLT3 test as a companion diagnostic for RYDAPT in newly diagnosed FLT3+ AML.